Thank you for attending the Vascular Scientific Sessions presented by the Society for Vascular Medicine. SVM VSS Attendees may click here to login and access the sessions recordings.
Non-Attendees may purchase the on-demand content via the link below. CME/MOC information is available in the Learner Notification.
SVM Doctorate/Fellow Members $750 (Non-Members $950)
SVM Trainee Associate Members $275 (Non-Members $450)
How to Get Your Certificate
Questions? Email Certificate@AmedcoEmail.com
The official time zone of the Vascular Scientific Sessions is Mountain Time
Start | End | Session/Event |
---|---|---|
2:00PM |
5:00PM |
Committee Meetings |
4:00PM |
5:00PM |
Vascular Medicine Journal Editorial Board |
5:00PM |
6:00PM |
Mentoring Session (pre-registration required) |
Start | End | Session/Event |
---|---|---|
6:45 AM |
7:45 AM |
Sponsored Breakfast |
7:55 AM |
8:00 AM |
Program Chair Welcome Ido Weinberg, MD |
8:00 AM |
9:15 AM |
Vascular Medicine Year-in-Review |
Intro: The Future of Vascular Medicine as a Specialty and the Role of Accreditation Joshua Beckman, MD |
||
Health Equity, Risk Factors and Population Health Phil Goodney, MD |
||
Basic and Translational Science Naomi Hamburg, MD |
||
Arterial disease Herb Aronow, MD |
||
Thrombosis & Venous Disease Damon Houghton, MD |
||
Aortic Disease Aaron Aday, MD |
||
|
|
Discussion |
9:15 AM |
9:30 AM |
Best of Vascular Medicine Journal 2021 Heather Gornik, MD |
9:30 AM |
10:30 AM |
Jay D. Coffman Young Investigator Award Finalists Presentations |
Coronavirus But Not Influenza Virus Infection Induces the Expression of Both Cellular and Soluble Urokinase Plasminogen Activator Receptor Sriganesh B. Sharma, MD, PhD, Damon Houghton, MD (Discussant) |
||
Characteristics of Non-Response to Exercise Therapy in People with Peripheral Artery Disease: Results from Five Randomized Clinical Trials Pooja Nayak, MD, Umberto Campia, MD (Discussant) |
||
Association of HIV Infection with Clinical Features and Outcomes of Patients with Aortic Aneurysms Omar Chehab, MD, MSc, Nicholas Leeper, MD (Discussant) |
||
|
|
Effects of Ischemic Leg Sympton-Inducing Exercise on Simultaneous Improvement in Patient Reported Outcomes and Six-Minute Walk Distance in Peripheral Artery Disease: The Lite Randomized Clinical Trial Mary O. Whipple, PhD, RN, PHN, Marc Bonaca, MD (Discussant) |
10:30 AM |
10:45 AM |
Break |
10:45 AM |
12:15 PM |
Peripheral Artery Disease Session |
VOYAGER-PAD Overview Marc Bonaca, MD |
||
PAD Disparities in Care and in Clinical Trial Research Jennifer Rymer, MD |
||
What is small vessel disease and what does it mean? Michael Jaff, MD |
||
Supervised Exercise and Medical Management of the Patient with Lower Extremity Claudication: Updates and a Review of the Data Mary McDermott, MD |
||
CASE: The Endovascular Approach to the Patient with Lower Extremity PAD (Claudication and CLTI) Justin Morrison, MD |
||
The Endovascular Approach to the Patient with Lower Extremity PAD (Claudication and CLTI) Kevin Rogers, MD |
||
CASE: The surgical approach to the patient with lower extremity PAD (Claudication and CLTI) Aishat Folaranmi Mustapha, MD |
||
The Surgical Approach to the Patient with Lower Extremity PAD (Claudication and CLTI) Andrea Obi, MD |
||
|
|
Panel Discussion |
12:15 PM |
1:30 PM |
Sponsored Lunch |
1:30 PM |
3:00 PM |
Thrombosis and Anticoagulation Session |
Pulmonary Embolism in 2022: From imaging to post-acute care (including ESC guidelines on risk stratification) Lukas Hobohm, MD |
||
Case: Holding anticoagulation (Bleeding and Peri-procedural). When is it not simple to do? + Discussion Leili Behrooz, MD |
||
COVID thrombosis Behnood Bekdeli, MD |
||
My patient has cancer. Anticoagulation in VTE prone populations Kathryn Hassell, MD |
||
Case: Procedures and long-term anticoagulation and antiplatelet agents (MTS etc.) + Discussion Abdelrhman Abumoawad, MD |
||
Endovascular management of VTE: What's in our toolbox? Kush Desai, MD |
||
|
|
Multimodality imaging of thrombotic disease: Beyond compression ultrasound Sasan Partovi, MD |
3:00 PM |
3:30 PM |
Break |
3:30 PM |
4:30 PM |
Moderator Poster Session and Featured Poster Presentations |
Post-Pulmonary Embolism Syndrome: Contemporary Incidence and Utilization of Diagnostic Testing in a National Cohort S. Nabeel Hyder, MD |
||
Recurrent Limb Events After Endovascular Femoral Revascularization and Risk of Death Scott Kinlay, MD |
||
Living in Food Deserts and Major Adverse Limb Events in Patients with Peripheral Artery Disease Rayan S. El-Zein, DO |
||
|
|
Major Bleeding, Recurrence and Mortality in Chronically Immobilized Patients Treated for Venous Thromboembolism Andrew Dicks, MD |
4:30 PM |
5:00 PM |
Break |
5:00 PM |
6:00 PM |
Vascular Jeopardy |
6:00 PM |
7:00 PM |
Opening Reception |
Start | End | Session/Event | Start | End | Session/Event | |
---|---|---|---|---|---|---|
7:00 AM |
8:00 AM |
Sponsored Breakfast |
||||
8:00 AM |
9:00 AM |
SVM Business Meeting |
||||
9:00 AM |
9:20 AM |
Presidential Address Herb Aronow, MD |
||||
9:20 AM |
10:00 AM |
Late Breaking Science |
||||
Evaluation of Takayasu's Arteritis Disease Activity by Ultrasound Localization Microscopy Guillaume GOUDOT, MD, PhD |
||||||
Natural History of Segmental Arterial Mediolysis Robert McBane, MD |
||||||
Identifying Genetic Variants Associated with Cerebral Atherosclerosis Using an International Classification of Diseases (ICD)-10 Based Approach in the UK Biobank Fahad Alkhalfan, MD |
||||||
|
|
Randomized, Controlled Trial of a Digital Therapeutic App Providing Nutritional Cognitive Behavioral Therapy for the Treatment of Type 2 Diabetes Marc Bonaca, MD |
||||
10:00 AM |
10:25 AM |
Awards Presentation |
||||
10:25 AM |
11:00 AM |
Break |
||||
11:00 AM |
12:00 PM |
Carotid Artery Session |
||||
Non-atherosclerotic Carotid Artery Disease: Differential Diagnosis and Evaluation: From Imaging to Testing to Care Fiorella Llanos, MD |
||||||
Predicting Health Status Outcomes in Carotid Disease Kim Smolderen, PhD |
||||||
Asymptomatic Carotid Disease - Diagnosis, Evaluation, Imaging, Tools to Decide When to Intervene Stan Henkin, MD |
||||||
Medical Therapy for Carotid Disease - What has been done in the trials to date and what is standard of care now? Aaron Aday, MD |
||||||
|
|
Interactive Case and Panel Discussion Yulanka Castro, MD |
||||
12:00 PM |
1:15 PM |
Sponsored Lunch |
|
|
|
|
|
|
Concurrent Sessions |
||||
1:15 PM |
2:45 PM |
Risk Factor Modification Session: Modern medical treatment of diabetes **NEW THIS YEAR** |
1:15 PM |
2:45 PM |
Vascular POCUS Workshop **NEW THIS YEAR** |
|
Metformin and insulin still has a role in DM, even in patients with PAD Tamar Polonksy, MD |
Know your PoCUS machine and ways to incorporate in routine physical exam and bedside procedures Gaurav Parmar, MD |
|||||
Real world benefits of GLP-1 agonists Cecilia Low Wang, MD |
PoCUS in PE evaluation- RV strain/dysfunction Haseeb Qazi, MD |
|||||
Avoiding SGLT2-inhibitors in PAD, an Outdated Warning? Naomi Hamburg, MD |
PoCUS for vascular access Mitch Weinberg, MD |
|||||
Discussion |
PoCUS to assess proximal LE DVT Michael Levy, MD |
|||||
Risk Factor Modification Session: Hyperlipidemia treatment in 2022: From statins and beyond |
PoCUS to measure size of abdominal aorta and screen for AAA Billy Chacko, MD |
|||||
2022 Update in Statins and Statin Intolerance David Saxon, MD |
||||||
Here's when I consider a PCSK9i Marc Bonaca, MD |
||||||
Ezetemibe still has a role, despite data about PCSK9i Shireen Khoury, MD |
||||||
Discussion |
||||||
Risk Factor Modification Session: Hypertension: Update for the 2020's |
||||||
|
|
Hypertension Update for the 2020’s: Case based approach to HTN management in special populations Steven Simon, MD |
|
|
|
|
2:45 PM |
3:00 PM |
Break |
||||
3:00 PM |
3:45 PM |
Updates in Renal and Mesenteric Artery Disease |
||||
Renal artery stenosis and HTN Anna Krawisz, MD |
||||||
CASE: Renal artery stenosis and HTN Ihsan Kaadan, MD |
||||||
Renal artery aneurysm and dissection Andrew Dicks, MD |
||||||
CASE: Renal artery aneurysm and dissection Siri Neelati, MD |
||||||
Mesenteric artery stenosis and MALS: Symptoms, imaging and management challenges Leben Tefera, MD |
||||||
|
|
CASE Mesenteric artery stenosis and MALS Kunal Mishra, MD |
||||
3:45 PM |
4:45 PM |
SVM-AVF Joint Session |
||||
|
|
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial Suresh Vendantham, MD |
||||
|
|
When should IVC stenting be considered: what is the appropriate indication? Minhaj Khaja, MD |
||||
|
|
Venous Leg Ulcers without GSV Reflux: What do you do next? William Marston, MD |
||||
|
|
Drugs for CVD and Lymphedema: When and what to use? Eri Fukaya, MD |
||||
|
|
How to Apply Different Types of Compression: When, What, How Syed Ahsan, MD |
||||
|
|
Glycocalyx and Vascular Permeability Stanley Rockson, MD |
||||
|
|
Panel Discussion |
||||
4:45 PM |
5:30 PM |
Networking Happy Hour |
||||
5:30 PM |
6:45 PM |
Cases over Canapes |
||||
The infrequent 'Is" of abdominal pain Andrew Dicks, MD |
||||||
Good things do not always come in small packages Amanda Morrison, MD |
||||||
When coughing up blood is a problem Christopher Caras MD |
||||||
|
|
Complicated things in a 23 y/o male with a complicated condition Gayatri Suresh Kumar, MD |
Start | End | Session/Event |
---|---|---|
5:30 AM |
6:30 PM |
SVM 5K Fun Run 22 In Memory of Dr. William R. Hiatt |
6:30 AM |
7:15 AM |
Sponsored Breakfast |
7:15 AM |
8:30 AM |
"If it were me, I would suggest…" **NEW THS YEAR** |
Chronically implanted IVC filters: An innocent bystander or a culprit that must be managed? Jessica Bjorklund, MD |
||
The role of catheter-directed thrombolysis for management of acute iliofemoral deep vein thrombosis Bob Schainfeld, MD |
||
The patient with the advanced wound: Leave no procedure unused or primary amputation? Mark Nehler, MD |
||
Anti-platelet / antithrombotic management among patients undergoing peripheral VASCULAR interventions Connie Hess, MD |
||
|
|
Endarterectomy for Managing Atherosclerotic Peripheral Artery Disease Involving the Common Femoral Artery Endarterectomy for Managing Atherosclerotic Peripheral Artery Disease Involving the Common Femoral Artery Mitchell Weinberg, MD and Mark Nehler, MD |
8:30 AM |
10:00 AM |
Hands-on Vascular Lab |
|
|
Bedside US Demo: Skills Beyond the Arterial Physical Exam (remote demo) Raghu Kolluri, MD |
|
|
Complete ultrasound protocols and POCUS for lower extremity deep vein thrombosis: what to do if a formal ultrasound study is not timely available? Luis Eraso, MD |
|
|
Bedside US Demo: Skills Beyond the Venous Physical Exam (remote demo) Raghu Kolluri, MD |
|
|
Knobology: Pitfalls of Creating and Tips for Overcoming the Artifacts Sandra Yesenko, DHSc, MHS, RVT, RDMS and Natalia Fendrikova Mahlay, MD, RVPI |
|
|
Competency Assessment : Use of Simulation in Vascular Ultrasound Eugene Zierler, MD |
|
|
Discussion |
10:00 AM |
10:15 AM |
Break |
10:15 AM |
11:15 AM |
Great Debates in Vascular Medicine |
Asymptomatic carotid disease - optimal medical therapy versus revascularization? |
||
Asymptomatic carotid disease - optimal medical therapy versus revascularization? |
||
Intermediate Risk (Submassive) Pulmonary Embolism – medical therapy versus escalating therapy. |
||
Intermediate Risk (Submassive) Pulmonary Embolism – medical therapy versus escalating therapy. |
||
Do we need Renal Denervation for moderate and resistant hypertension? |
||
|
|
Do we need Renal Denervation for moderate and resistant hypertension? |
11:15 AM |
12:00 PM |
Tips for Readers: Where did I go wrong and why? |
|
|
Interpretation of Arterial and Venous Waveforms: Learning from the Errors of the Past Esther Kim, MD |
|
|
Pearls and Pitfalls in Venous Duplex Sundeep Shenoy, MD |
|
|
Arteriopathies and the Zebras: Where can we wrong? Randy Ramcharitar, MD |
|
|
Imaging Arterial Stents, Endografts, and Bypass Grafts: Knowing the Differences from Native Vessel Imaging Bryan Wells, MD |
THANK YOU TO OUR INDUSTRY PARTNERS!